Clinical Trial Update: [18F]-Fludarabine PET/MRI in Primary Central Nervous System Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating [18F]-Fludarabine PET/MRI in primary CNS lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Nervous System Lymphoma

Drugs mentioned

• 18F-Fludarabine (Fludarabine-18F)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Primary Central Nervous System Lymphoma | Phase 1 | Status: COMPLETED